Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Currently, 60 million women of reproductive age (18-44 years old) worldwide, and approximately 3 million American women have diabetes mellitus, and it has been estimated that this number will double by 2030. Pregestational diabetes mellitus (PGD) is a significant public health problem that increases the risk for structural birth defects affecting both maternal and neonatal pregnancy outcome. The most common types of human structural birth defects associated with PGD are congenital heart defects and central nervous system defects. However, diabetes can induce birth defects in any other fetal organ. In general, the rate of birth defects increases linearly with the degree of maternal hyperglycemia, which is the major factor that mediates teratogenicity of PGD. Stringent prenatal care and glycemic control are effective means to reduce birth defects in PGD pregnancies, but cannot reduce the incidence of birth defects to the rate of that is seen in the nondiabetic population. Studies in animal models have revealed that PGD induces oxidative stress, which activates cellular stress signalling leading to dysregulation of gene expression and excess apoptosis in the target organs, including the neural tube and embryonic heart. Activation of the apoptosis signal-regulating kinase 1 (ASK1)-forkhead transcription factor 3a (FoxO3a)-caspase 8 pathway causes apoptosis in the developing neural tube leading to neural tube defects (NTDs). ASK1 activates the c-Jun-N-Terminal kinase 1/2 (JNK1/2), which leads to activation of the unfolded protein response and endoplasmic reticulum (ER) stress. Deletion of the ASK1 gene, the JNK1 gene, or the JNK2 gene, or inhibition of ER stress by 4-Phenylbutyric acid abrogates diabetes-induced apoptosis and reduces the formation of NTDs. Antioxidants, such as thioredoxin, which inhibits the ASK1-FoxO3a-caspase 8 pathway or ER stress inhibitors, may prevent PGD-induced birth defects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macintosh, M. C. M., Fleming, K. M., Bailey, J. A., Doyle, P., Modder, J., Acolet, D., Golightly, S., & Miller, A. (2006) · BMJ · doi:10.1136/bmj.38856.692986.ae · Cited by 673
Outcomes in Type 1 Diabetic Pregnancies
Jensen, D. M., Damm, P., Moelsted-Pedersen, L., Ovesen, P., Westergaard, J. G., Moeller, M., & Beck-Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2819 · Cited by 486
Fetal and neonatal outcomes of diabetic pregnancies
Yang, J., Cummings, E. A., OʼConnell, C., & Jangaard, K. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000231688.08263.47 · Cited by 352
Poor pregnancy outcome in women with type 2 diabetes
Clausen, T. D., Mathiesen, E., Ekbom, P., Hellmuth, E., Mandrup-Poulsen, T., & Damm, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.323 · Cited by 318
Schaefer-Graf, U. M., Buchanan, T. A., Xiang, A., Songster, G., Montoro, M., & Kjos, S. L. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70217-1 · Cited by 270
Hanson, U., Persson, B., & Thunell, S. (1990) · Diabetologia · doi:10.1007/bf00401047 · Cited by 176
Cited by
Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis
Nakano, H., Minami, I., Braas, D., Pappoe, H., Wu, X., Sagadevan, A., Vergnes, L., Fu, K., Morselli, M., Dunham, C., et al. (2017) · eLife · doi:10.7554/elife.29330 · Cited by 195
“Thus, despite the established association between maternal hyperglycemia and malformation of the fetal heart, little is known about how glucose levels impact cardiomyocyte development and how hyperglycemia affects heart formation in diabetic pregnancy (Gaspar et al., 2014).”
BackgroundWahabi, H. A., Fayed, A., Esmaeil, S., Elmorshedy, H., Titi, M. A., Amer, Y. S., Alzeidan, R. A., Alodhayani, A. A., Saeed, E., Bahkali, K. H., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237571 · Cited by 130
Wu, Y., Reece, E. A., Zhong, J., Dong, D., Shen, W.-B., Harman, C. R., & Yang, P. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.036 · Cited by 100
Hildén, K., Hanson, U., Persson, M., Magnuson, A., Simmons, D., & Fadl, H. (2019) · Diabetic Medicine · doi:10.1111/dme.13843 · Cited by 42
Metadata
- Authors
- Gabbay-Benziv, R.
- Venue
- World Journal of Diabetes
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 6
- Issue
- 3
- Pages
- 481
- ISSN
- 1948-9358 (ISSN-L)
- OpenAlex
- W1979187096
- Cited by
- 170
- References
- 6
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. https://app.cochat.ai/papers/10.4239/wjd.v6.i3.481
- The paper
- Gabbay-Benziv, R. (2015). Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. World Journal of Diabetes. https://doi.org/10.4239/wjd.v6.i3.481
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.